From the data of Pellagatti, A. et al. in 2010 and 2013 [23,24], anemic patients were selected by removing the data with Hb > 11.0 g/dL and compared the expression levels of GSN mRNA between MDS subgroups. This evidence concerns the gene GSTM1 and myelodysplastic syndrome.